1. Home
  2. RANI vs RETO Comparison

RANI vs RETO Comparison

Compare RANI & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • RETO
  • Stock Information
  • Founded
  • RANI 2012
  • RETO 1999
  • Country
  • RANI United States
  • RETO China
  • Employees
  • RANI N/A
  • RETO N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • RETO Multi-Sector Companies
  • Sector
  • RANI Health Care
  • RETO Consumer Discretionary
  • Exchange
  • RANI Nasdaq
  • RETO Nasdaq
  • Market Cap
  • RANI 23.2M
  • RETO 24.7M
  • IPO Year
  • RANI 2021
  • RETO 2017
  • Fundamental
  • Price
  • RANI $0.47
  • RETO $1.31
  • Analyst Decision
  • RANI Strong Buy
  • RETO
  • Analyst Count
  • RANI 4
  • RETO 0
  • Target Price
  • RANI $7.75
  • RETO N/A
  • AVG Volume (30 Days)
  • RANI 413.1K
  • RETO 212.0K
  • Earning Date
  • RANI 11-13-2025
  • RETO 10-27-2025
  • Dividend Yield
  • RANI N/A
  • RETO N/A
  • EPS Growth
  • RANI N/A
  • RETO N/A
  • EPS
  • RANI N/A
  • RETO N/A
  • Revenue
  • RANI $1,200,000.00
  • RETO $1,828,976.00
  • Revenue This Year
  • RANI N/A
  • RETO N/A
  • Revenue Next Year
  • RANI N/A
  • RETO N/A
  • P/E Ratio
  • RANI N/A
  • RETO N/A
  • Revenue Growth
  • RANI N/A
  • RETO N/A
  • 52 Week Low
  • RANI $0.39
  • RETO $1.20
  • 52 Week High
  • RANI $3.75
  • RETO $15.54
  • Technical
  • Relative Strength Index (RSI)
  • RANI 41.49
  • RETO 33.12
  • Support Level
  • RANI $0.47
  • RETO $1.20
  • Resistance Level
  • RANI $0.51
  • RETO $2.26
  • Average True Range (ATR)
  • RANI 0.04
  • RETO 0.26
  • MACD
  • RANI -0.00
  • RETO -0.04
  • Stochastic Oscillator
  • RANI 21.26
  • RETO 10.74

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: